CAS 1408245-02-2

(2S,3R,4R,5R,6R)-2-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

CAS : 1408245-02-2

(2S,3R,4R,5R,6R)-2-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol is a drug that inhibits the sodium-dependent glucose transporter 1 (SGLT1). SGLT1 is responsible for renal glucose reabsorption and this drug prevents the reabsorption of glucose in the kidneys. (2S,3R,4R,5R,6R)-2-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol is not active against cancer cells or growth factors. It has a safety profile that can be tolerated by diabetic patients without any adverse effects. The medication also has an inhibitor binding site on the cellular level and

Formule : C₂₁H₂₅ClO₆

Degré de pureté : Min. 95%

Masse moléculaire : 408.9 g/mol

Ref: 3D-IGC24502

Dapagliflozin Galacto Isomer

CAS : 1408245-02-2

Formule : C₂₁H₂₅ClO₆

Masse moléculaire : 408.9

Ref: ST-EA-CP-D8060